Statera Biopharma, Inc. Total Assets
Statera Biopharma, Inc. had Total Assets of $12.75 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2022-11-14
- 2022-09-30: Assets $12.75M.
- 2022-06-30: Assets $13.54M.
- 2022-03-31: Assets $13.51M.
- 2021-12-31: Assets $21.17M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2022-09-30 | $12.75M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $13.54M 10-Q · filed 2022-10-28 | |
| 2022-03-31 | $13.51M 10-Q · filed 2022-10-21 | |
| 2021-12-31 | $21.17M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $98.04M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $13.83M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $14.70M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.04M 10-K · filed 2022-10-06 | $2.32M 10-K · filed 2021-03-22 |
| 2020-12-30 | $1.04M 10-Q · filed 2021-11-15 | |
| 2020-09-30 | $3.23M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $4.08M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.86M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.04M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $2.23M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $3.09M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.78M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $4.53M 10-K · filed 2020-04-15 | |
| 2018-09-30 | $5.70M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $7.06M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.37M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $9.63M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $10.87M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $12.23M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $13.88M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $15.96M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $17.03M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $17.96M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $19.80M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $20.88M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $24.66M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $6.85M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $10.68M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $9.81M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $12.47M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $15.23M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $17.67M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $14.70M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $19.69M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $17.85M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $25.18M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $32.01M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $21.67M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $24.63M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $26.52M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $32.13M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $28.12M 10-Q/A · filed 2011-11-14 | |
| 2011-06-30 | $35.60M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $19.89M 10-K · filed 2012-03-13 |